Results for tag: "Hyperuricemia Drug"

Hyperuricemia is a condition in which the body has an abnormally high level of uric acid in the blood. It is a common complication of hematological diseases, such as leukemia, lymphoma, and multiple myeloma. As a result, the treatment of hyperuricemia is an important part of the management of hematological diseases. The hyperuricemia drug market is composed of a variety of drugs used to reduce uric acid levels in the blood. These drugs include xanthine oxidase inhibitors, uricosuric agents, and uric acid-lowering agents. Xanthine oxidase inhibitors are the most commonly used drugs for hyperuricemia, as they reduce the production of uric acid in the body. Uricosuric agents increase the excretion of uric acid from the body, while uric acid-lowering agents reduce the absorption of uric acid from the diet. The hyperuricemia drug market is highly competitive, with many companies offering a variety of drugs for the treatment of hyperuricemia. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more